Literature DB >> 33290820

Advanced machine-learning techniques in drug discovery.

Moe Elbadawi1, Simon Gaisford2, Abdul W Basit3.   

Abstract

The popularity of machine learning (ML) across drug discovery continues to grow, yielding impressive results. As their use increases, so do their limitations become apparent. Such limitations include their need for big data, sparsity in data, and their lack of interpretability. It has also become apparent that the techniques are not truly autonomous, requiring retraining even post deployment. In this review, we detail the use of advanced techniques to circumvent these challenges, with examples drawn from drug discovery and allied disciplines. In addition, we present emerging techniques and their potential role in drug discovery. The techniques presented herein are anticipated to expand the applicability of ML in drug discovery.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 33290820     DOI: 10.1016/j.drudis.2020.12.003

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  6 in total

Review 1.  Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.

Authors:  Vertika Gautam; Anand Gaurav; Neeraj Masand; Vannajan Sanghiran Lee; Vaishali M Patil
Journal:  Mol Divers       Date:  2022-07-11       Impact factor: 3.364

2.  Accelerating 3D printing of pharmaceutical products using machine learning.

Authors:  Jun Jie Ong; Brais Muñiz Castro; Simon Gaisford; Pedro Cabalar; Abdul W Basit; Gilberto Pérez; Alvaro Goyanes
Journal:  Int J Pharm X       Date:  2022-06-09

3.  Harnessing machine learning for development of microbiome therapeutics.

Authors:  Laura E McCoubrey; Moe Elbadawi; Mine Orlu; Simon Gaisford; Abdul W Basit
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 4.  Deep learning tools for advancing drug discovery and development.

Authors:  Sagorika Nag; Anurag T K Baidya; Abhimanyu Mandal; Alen T Mathew; Bhanuranjan Das; Bharti Devi; Rajnish Kumar
Journal:  3 Biotech       Date:  2022-04-09       Impact factor: 2.893

Review 5.  Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG).

Authors:  Sandra Brasil; Mariateresa Allocca; Salvador C M Magrinho; Inês Santos; Madalena Raposo; Rita Francisco; Carlota Pascoal; Tiago Martins; Paula A Videira; Florbela Pereira; Giuseppina Andreotti; Jaak Jaeken; Kristin A Kantautas; Ethan O Perlstein; Vanessa Dos Reis Ferreira
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

6.  Virtual screening and activity evaluation of multitargeting inhibitors for idiopathic pulmonary fibrosis.

Authors:  Rui Wang; Jian Xu; Rong Yan; Huanbin Liu; Jingxin Zhao; Yuan Xie; Wenbin Deng; Weiping Liao; Yichu Nie
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.